These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 16258455

  • 1. Current treatment recommendations for stage III non-small-cell lung carcinoma.
    Davis MP, Sause WT.
    Clin Adv Hematol Oncol; 2003 Oct; 1(10):587-93. PubMed ID: 16258455
    [Abstract] [Full Text] [Related]

  • 2. Treatment of locally advanced non-small cell lung cancer.
    Fidler MJ, Kim AW, Zusag T, Bonomi P.
    Clin Adv Hematol Oncol; 2009 Jul; 7(7):455-64, 479-80. PubMed ID: 19701153
    [Abstract] [Full Text] [Related]

  • 3. Sequencing chemotherapy, radiotherapy and surgery in combined modality treatment of stage III nonsmall cell lung cancer.
    Maas KW, El Sharouni SY, Smit EF, Schramel FM.
    Curr Opin Pulm Med; 2007 Jul; 13(4):297-304. PubMed ID: 17534176
    [Abstract] [Full Text] [Related]

  • 4. Which patients with stage III non-small cell lung cancer should undergo surgical resection?
    Patel V, Shrager JB.
    Oncologist; 2005 May; 10(5):335-44. PubMed ID: 15851792
    [Abstract] [Full Text] [Related]

  • 5. Combined modality therapy for stage III non-small-cell lung cancer.
    Anderson CS, Curran WJ.
    Semin Radiat Oncol; 2010 Jul; 20(3):186-91. PubMed ID: 20685581
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Management of unresectable stage III non-small-cell lung cancer with combined-modality therapy: a review of the current literature and recommendations for treatment.
    Bayman NA, Blackhall F, Jain P, Lee L, Thatcher N, Faivre-Finn C.
    Clin Lung Cancer; 2008 Mar; 9(2):92-101. PubMed ID: 18501095
    [Abstract] [Full Text] [Related]

  • 10. Combined modality therapy for stage III non-small cell lung cancer.
    Stinchcombe TE, Fried D, Morris DE, Socinski MA.
    Oncologist; 2006 Mar; 11(7):809-23. PubMed ID: 16880240
    [Abstract] [Full Text] [Related]

  • 11. Overview of the randomized phase III trials in non-small cell lung cancer in North America.
    Kelly K.
    Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-2-S8-5. PubMed ID: 9207308
    [Abstract] [Full Text] [Related]

  • 12. [Multimodal therapy of small cell and non-small cell lung carcinoma].
    Serke M, Kollmeier J.
    Dtsch Med Wochenschr; 2007 Jun 01; 132(22):1221-4. PubMed ID: 17520508
    [Abstract] [Full Text] [Related]

  • 13. The emergence of a unique population in non-small cell lung cancer: systemic or loco-regional relapse following postoperative adjuvant platinum-based chemotherapy.
    Socinski MA, Stinchcombe TE, Hayes DN, Morris DE.
    Semin Oncol; 2006 Feb 01; 33(1 Suppl 1):S32-8. PubMed ID: 16472707
    [Abstract] [Full Text] [Related]

  • 14. Stage IIIB non-small-cell lung cancer.
    Rendina EA, Venuta F, De Giacomo T, Furio Coloni G.
    Chest Surg Clin N Am; 2001 Feb 01; 11(1):101-19, viii. PubMed ID: 11253593
    [Abstract] [Full Text] [Related]

  • 15. Post-chemotherapy gross tumor volume is predictive of survival in patients with stage III non-small cell lung cancer treated with combined modality therapy.
    Stinchcombe TE, Morris DE, Moore DT, Bechtel JH, Halle JS, Mears A, Deschesne K, Rosenman JG, Socinski MA.
    Lung Cancer; 2006 Apr 01; 52(1):67-74. PubMed ID: 16499996
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Treatment of advanced non-small cell lung cancer in the elderly.
    Sequist LV, Fidias P.
    Semin Respir Crit Care Med; 2005 Jun 01; 26(3):289-97. PubMed ID: 16052430
    [Abstract] [Full Text] [Related]

  • 18. A randomized study of involved-field irradiation versus elective nodal irradiation in combination with concurrent chemotherapy for inoperable stage III nonsmall cell lung cancer.
    Yuan S, Sun X, Li M, Yu J, Ren R, Yu Y, Li J, Liu X, Wang R, Li B, Kong L, Yin Y.
    Am J Clin Oncol; 2007 Jun 01; 30(3):239-44. PubMed ID: 17551299
    [Abstract] [Full Text] [Related]

  • 19. Granulocyte growth factors in the treatment of non-small cell lung cancer (NSCLC).
    Grossi F, Tiseo M.
    Crit Rev Oncol Hematol; 2006 Jun 01; 58(3):221-30. PubMed ID: 16697211
    [Abstract] [Full Text] [Related]

  • 20. How to evaluate the risk/benefit of trimodality therapy in locally advanced non-small-cell lung cancer.
    Kunitoh H, Suzuki K.
    Br J Cancer; 2007 May 21; 96(10):1498-503. PubMed ID: 17473830
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.